New Anticancer Treatment, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

New Anticancer Treatment
Beschreibung

New Anticancer Treatment

First Treatment Regimen:
Beschreibung

The patient has received new or additional anticancer treatment for NSCLC since discontinuing study drug. Record treatment and start date:

Datentyp

text

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0007131
Start Date
Beschreibung

Anticancer Treatment Start Date

Datentyp

date

Alias
UMLS CUI [1]
C3173309

Ähnliche Modelle

New Anticancer Treatment, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
New Anticancer Treatment
New Anticancer Treatment for NSCLC
Item
First Treatment Regimen:
text
C0087111 (UMLS CUI [1,1])
C0007131 (UMLS CUI [1,2])
Anticancer Treatment Start Date
Item
Start Date
date
C3173309 (UMLS CUI [1])